"ViroCure is at the forefront of cancer therapeutics research and vaccine development with oncolytic virotherapy. ViroCure finds and develops unique viruses to safely and effectively treat various types of cancer illnesses with no current cure regimen. The company is striving to find and catalog many different oncolytic viral or vaccine species for cancer and other therapeutics in the near future. Their naturally occurring, modified, engineered viruses selectively infect and kill cancer cells and activate anti-cancer immune responses, with negligible side effects on normal cells. With 6 patents spanning 4 countries (including the United States) and multiple upcoming patents already in progress, ViroCure is dedicated to continuously discovering new oncolytic viruses and becoming a market leader in the new fourth generation of cancer therapeutics."